Myocardial abscess

Jump to navigation Jump to search
Myocardial abscess
Myocardial abscess: Candida: Gross, natural color excellent depiction myocardial abscesses caused by Candida tropicalis. A 51yo man with acute monocytic leukemia.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

WikiDoc Resources for Myocardial abscess

Articles

Most recent articles on Myocardial abscess

Most cited articles on Myocardial abscess

Review articles on Myocardial abscess

Articles on Myocardial abscess in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Myocardial abscess

Images of Myocardial abscess

Photos of Myocardial abscess

Podcasts & MP3s on Myocardial abscess

Videos on Myocardial abscess

Evidence Based Medicine

Cochrane Collaboration on Myocardial abscess

Bandolier on Myocardial abscess

TRIP on Myocardial abscess

Clinical Trials

Ongoing Trials on Myocardial abscess at Clinical Trials.gov

Trial results on Myocardial abscess

Clinical Trials on Myocardial abscess at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Myocardial abscess

NICE Guidance on Myocardial abscess

NHS PRODIGY Guidance

FDA on Myocardial abscess

CDC on Myocardial abscess

Books

Books on Myocardial abscess

News

Myocardial abscess in the news

Be alerted to news on Myocardial abscess

News trends on Myocardial abscess

Commentary

Blogs on Myocardial abscess

Definitions

Definitions of Myocardial abscess

Patient Resources / Community

Patient resources on Myocardial abscess

Discussion groups on Myocardial abscess

Patient Handouts on Myocardial abscess

Directions to Hospitals Treating Myocardial abscess

Risk calculators and risk factors for Myocardial abscess

Healthcare Provider Resources

Symptoms of Myocardial abscess

Causes & Risk Factors for Myocardial abscess

Diagnostic studies for Myocardial abscess

Treatment of Myocardial abscess

Continuing Medical Education (CME)

CME Programs on Myocardial abscess

International

Myocardial abscess en Espanol

Myocardial abscess en Francais

Business

Myocardial abscess in the Marketplace

Patents on Myocardial abscess

Experimental / Informatics

List of terms related to Myocardial abscess

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]

overview

A cardiac abscess is a suppurative infection of the myocardium, endocardium, native or prosthetic valve tissue. Similar to other abscesses, it develops either by dissemination from a distant source such as bacteremia or sepsis or by direct extension of a pre-existing cardiac infective focus. Infective endocarditis has long been identified as the main cause of the latter. Although the incidence of cardiac abscesses continues to be investigated, it is presumably higher than noted postmortem and is of great importance when deciding the prognosis and management of patients. A single organism causes cardiac abscesses, usually Staphylococcus aureus or Escherichia coli. Less typically, polymicrobial abscesses have been noted. Important complications of a cardiac abscess, whether alone or with valve tissue, are conduction abnormalities on electrocardiogram (ECG). The incidence of perivalvular abscess among patients with infective endocarditis is between 30% to 40%, with the aortic valve having a higher predisposition than the mitral valve and annulus. Native aortic valve endocarditis, usually located in a weak part of the annulus near the atrioventricular node (AV), clearly demonstrates the anatomic predisposition and exemplifies why abscesses and heart block presents as frequent sequelae. Perivalvular abscesses are also more common with prosthetic valves. In this case, the annulus instead of the leaflet is usually the primary site of infection. The degree of conduction disruption, therefore, depends on the extent of the involvement of the conduction system and is more commonly seen in perivalvular aortic abscesses. Additionally, the severe extension of perivalvular infection can also result in extrinsic coronary compression, or disruption, leading to an acute coronary syndrome. Thus far, only aortic valve involvement and current IV drug use have been prospectively identified as independent risk factors for a perivalvular abscess. Any patient with a cardiac abscess, regardless of all other factors, has an increased risk of embolization, morbidity, and mortality. Prophylaxis remains a longstanding subject in the matter of prevention of IE or cardiac abscess. Thus far, prophylaxis is mostly based on observational studies and, in fact, places such as the United Kingdom no longer endorse antibiotic prophylaxis for dental procedures to prevent IE, the leading source of the cardiac abscess. One point against prophylaxis is the fact that tooth brushing has been proven to cause bacteremia and, therefore, makes it difficult to assess the rare versus high magnitude transient bacteremia and its effect on IE and its sequelae. For this reason, the United States and European countries have agreed that the use of prophylaxis is reserved only for those at "highest risk." On that same matter, the widespread use of antibiotics for the prevention and treatment of IE and abscesses could potentially create a setting where there will be an increased incidence of polymicrobial infection and antibiotic resistance, especially in immunocompromised patients.

Historical perspective

Pathophysiology

Myocardial abscess is a pus-containing infection of the endocardium, myocardium, prosthetic or native valves, perivalvular structures or the cardiac conduction system. [2] [3]

Pathogenesis

Post-mortem examination,of myocardial abscess, showed following pathological changes:

Macroscopic finding

  • The cardiac area was greatly enlarged, and when the pericardial sac was opened, it was found to contain 600 cc of partially clotted blood.
  • The parietal pericardium was blood tinged but smooth and glistening throughout [10] [11] [12] .
  • The epicardium was normal in appearance over the anterior aspect of the heart but glassy and coated with a thin layer of fibrinous exudate in the posterior aspect.
  • The tear involved the entire thickness of the myocardium so that a probe could be passed through it into the left ventricular cavity without resistance.
  • The surrounding myocardium was infiltrated by blood and flabby in consistence in an area about 6 cm in diameter.
  • Externally and on cut section this area displayed a variegated tinge from reddish brown to yellowish gray.
  • Clusters of honey-combed pockets, each pin head in size or larger, were scattered throughout this area.
  • Grossly, these pockets were suggestive of small abscesses and contained a thick, golden-yellow material.
  • The coronary arteries were diffusely narrowed, with atheroma formation and calcification.
  • The right coronary artery was occluded a short distance below its main stem by a firmly adherent, friable, yellowish-brown thrombotic mass.
  • Examination of the cardiac chambers revealed a laminated thrombus on the posterior aspect of the left ventricle[13].

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Microscopic finding

  • Myocardial infarct the microscopical sections showed an almost complete obliteration of the normal architecture[14] [15].
  • The muscle fibers displayed loss of striations and of nuclear patterns and seemed fused together into an amorphous mass of eosinophilic material.
  • The capillaries in the area were congested, and extravasated red cells were present throughout.
  • There was a concomitant marked infiltration of polymorphonuclear leukocytes either scattered or in clusters, and this extended into the epicardium.
  • The leukocytes were not well preserved; the majority were fused together or showed karyorrhexis and karyolysis resulting in a scattering of cellular débris.
  • The endocardial mural thrombus consisted of amorphous eosinophilic material and was interspersed with white cells and cellular débris.
  • The mural thrombus merged indistinctly into the adjacent necrotic myocardium.
  • The thrombotic mass in the lumen of the right coronary artery showed incipient organization with intimal histiocytic and fibroblastic proliferation and atheromatous changes[16].

Causes

Endocarditis

Bacteremia

Myocardial infarction

Other settings associated with myocardial abscesses that have been reported in the literature include the following:

Differential Diagnosis

  • Thrombotic nonbacterial endocarditis/Marantic endocarditis
  • Vasculitis
  • Temporal arteritis
  • SLE/Libman-Sacks endocarditis
  • Connective tissue disease
  • Fever of unknown origin (FUO)
  • Intra-abdominal infections
  • Septic pulmonary infarction

Myocardial Abscess should be differentiated from other diseases presenting with fever, chest pain and anorxia. The differentials include the following:[24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43]

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
CT scan and MRI EKG Chest X-ray Tachypnea Tachycardia Fever Chest Pain Hemoptysis Dyspnea on Exertion Wheezing Chest Tenderness Nasalopharyngeal Ulceration Carotid Bruit
Pulmonary embolism
  • On CT angiography:
    • Intra-luminal filling defect
  • On MRI:
    • Narrowing of involved vessel
    • No contrast seen distal to obstruction
    • Polo-mint sign (partial filling defect surrounded by contrast)
✔ (Low grade) ✔ (In case of massive PE) - - - -
Infective Endocarditis
  • Goldberg's criteria may aid in diagnosis of left ventricular dysfunction: (High specificity)
    • SV1 or SV2 + RV5 or RV6 ≥3.5 mV
    • Total QRS amplitude in each of the limb leads ≤0.8 mV
    • R/S ratio <1 in lead V4
- - - - - -
Non-Bacterial Thrombotic Endocarditis
  • ST elevation
  • PR depression
✔ (Low grade) ✔ (Relieved by sitting up and leaning forward) - - - - -
  • May be clinically classified into:
    • Acute (< 6 weeks)
    • Sub-acute (6 weeks - 6 months)
    • Chronic (> 6 months)
Libman Sack Endocarditis - - - -
Vasculitis

Homogeneous, circumferential vessel wall swelling

-
Fever of unknown origin (FUO) - - - - - -

Epidemiology and Demographics

Risk Factors

Any septic focus can theoretically lead to myocardial abscess. These are the primary foci in order of frequency of causing myocardial abscess.

Spread from the urinary tract is the most common cause.
Spread from the gastrointestinal tract is the second common cause (e.g. perforated appendix, perforated colon cancer, diverticulitis ,and cohn’s disease.)
e.g. pott's disease or osteomyelitis
  • Hematogenous spread:
From distant septic foci.
Following chest abdominal or pelvic surgery.

Any condition compromising the immune system is a risk factor for developing myocardial abscess. The following were the risk factors in observed patients. [45]

Screening

According to the USPSTF, screening for retroperitoneal abscess is not recommended.

Natural History, Complications and Prognosis:

Natural history

If left untreated, myocardial abscess may cause heart block, septal rupture with very high incidence of morbidity and mortality.

Complications :

The following are potential complications of myocardial abscess:

  • Myocardial perforation
  • Significant clinical deterioration
  • Worsening CHF
  • Worsening heart sounds and murmurs
  • New-onset valvular regurgitation (100% of cases)
  • Poor response to antibiotics
  • Development of conduction defects or progression of heart block, such as bundle-branch block and atrioventricular block (45%)
  • Sudden onset of complete heart block or Mobitz type II block (highly specific)
  • Type of valve involvement, eg, aortic valve endocarditis (40%-85%)
  • Miscellaneous (severe recurrent ventricular arrhythmias, pericarditis [uncommon], infection of the prosthetic valves, right-sided endocarditis in patients with congenital heart disease)

Prognosis

  • Depending on the extent of the abscess at the time of diagnosis, the prognosis may vary.
  • The condition carries a very high mortality ranging from 30% to 75% without treatment. To reduce the morbidity and mortality of this disorder, it is imperative that a structured approach is developed to make an early diagnosis and begin treatment.
  • Even with therapy, mortality rates of 5% to 15% are not uncommon.

Diagnosis

History

  • A detailed history should be obtained from the patient presenting with infective endocarditis and chest pain.
  • Patients who have longstanding persistent bacteremia and who do not respond to antibiotic therapy.
  • Myocardial abscess is more prevalent in the period following mechanical interventions or surgery and in patients with HIV/AIDS-related myocarditis.

Symptoms

One must bear in mind certain constellations of symptoms that may raise the suggestion of myocardial abscess. For example, fever is the most common symptom, presenting in 80%-85% of patients. It is absent in some patients who are elderly; those who have CHF, severe debility, or chronic renal failure; and in patients with coagulase-negative staphylococcal infection and abscess. Another characteristic symptom is chills, which occurs in 42%-75% of cases.

Common symptoms:

Less common symptoms:

Physical Exam

General Appearance

Physical examination findings commonly encountered in myocardial abscess are mainly due to the underlying infective endocarditis. These include the following: Fever, Tachycardia, Murmur, especially changing or new murmur, Neurological abnormalities, Embolic event, Splenomegaly, Clubbing, Peripheral manifestations,Osler nodes, Splinter hemorrhages, Petechiae, Janeway lesions, Retinal lesions (Roth spots),Widening pulse pressure, especially with involvement of the aortic valve and progression of aortic regurgitation The patient is usually fatigued & looking ill due to the preexisting risk factor. In advanced cases with septicemia, the patient may be drowsy with decreased level of consciousness.[45]

Vital signs

Chest Examination

Lab Findings

Radiological Findings

  • In the past, most cases of myocardial abscess were found during autopsy. however, detection of myocardial abscess can now be achieved antemortem using multiple noninvasive imaging modalities, including transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE), indium In 111 radionuclide scintigraphy, computed tomography (CT) scan, and magnetic resonance imaging (MRI).

Chest radiography

  • chest radiography is perform to look for associated pulmonary infection.

Chest radiographic findings help assess for CHF.

Transthoracic echocardiography

  • TTE helps evaluate patients in whom endocarditis or myocardial abscess is suggested clinically. Findings frequently allow the morphologic confirmation of infection and increasingly aid in making decisions regarding management.
  • One must perform an echocardiographic evaluation in all patients suspected of having an intracardiac or pericardial infection, including those with negative blood culture findings.
  • TTE has a sensitivity of 23% and specificity of 98.6%.
  • According to Ellis et al (1985), the following 5 criteria are 86% sensitive and 88% specific for myocardial abscess:
    • Evidence of prosthetic valve rocking
    • Aneurysmal dilatation of the sinus of Valsalva
    • Posterior aortic root thickness greater than 10 mm
    • Perivalvular density in the septum of greater than 14 mm
    • The presence of "echo-free space" - Very specific but found relatively infrequently
  • Walker et al report a rare case of a myocardial abscess in valvular endocarditis that was difficult to assess with 2-dimensional TTE; however, real-time 3-dimensional contrast TTE allowed visualization of the full extent of the defect and its precise anatomical location, prior to successful surgical resection.

Transesophageal echocardiography

  • Although many patients with NVE involving the aortic or mitral valve can be adequately assessed using TTE, TEE with color flow and continuous pulsed Doppler is the state-of-the-art technique. Doppler and color-flow Doppler or contrast 2-dimensional echocardiography helps optimally define fistulas and abscess pockets and extensions. See the image below.
  • TEE has a sensitivity of 87% and specificity of 94.6%. Patients in whom an abscess is suggested but has not been detected using TEE should undergo MRI, including magnetic resonance angiography. ADD PIC

Scintigraphy

  • Indium In 111 leukocyte scintigraphy is especially useful in prosthetic valve endocarditis, in which echocardiography shows too much scatter.
  • A few milliliters of venous blood is drawn and mixed with an anticoagulant solution. The white blood cells are separated and labeled with radioactive isotope111 In, centrifuged, resuspended in isotonic sodium chloride solution, and reinjected into the patient. Images are then obtained with a gamma-ray camera within 16-24 hours. *The viable radioactive leukocytes potentially accumulate in the areas of inflammation or abscess. Obtain oblique views to avoid overshadowing by sternal accumulation.
  • The need for111 In scintigraphy is very low if TEE is used.

MRI

  • This is a good modality for helping delineate myocardial abscess. However, the portability and excellent resolution of echocardiography make it more practical than MRI.

CT scan

  • Only anecdotal reports of diagnosis are available. It is not very sensitive.

Intraoperative echocardiography

  • Although invasive, small abscesses can be detected in the operating room by means of intraoperative echocardiography, which may enable the operating surgeon to drain the abscess effectively.

Other Diagnostic Studies

Electrocardiography

  • New-onset and persistent electrocardiographic conduction abnormalities may be observed. Gradual PR prolongation may be observed, and it may suggest development of valve ring abscess.
  • Although not a sensitive indicator of perivalvular infection or abscess (28%), these findings are relatively specific (85-90%). See the image below.

Tests of immune system stimulation

  • Tests results may show disease activity, but the tests are costly and not very efficient for diagnosis or monitoring response to therapy
  • These may include testing of circulating immune complexes, rheumatoid factor, quantitative immune globulin, cryoglobulins, and C-reactive protein.

Serologic tests

  • Serological test findings are used to evaluate cardiac sepsis in which blood culture findings are negative.
  • Tests to detect antibodies to ribitol teichoic acids from staphylococci may help distinguish uncomplicated S aureus bacteremia from that associated with cardiac involvement.
  • These tests have not been used in clinical applications because of their lack of adequate specificity or predictive value.

Procedures

  • Cardiac catheterization may add very little to the imaging studies and is not recommended unless coronary angiography is needed for patients undergoing valve surgery who also may have significant coronary artery disease.

Treatment

Medical treatment

  • Intravenous antibiotics should be administered in a timely fashion once a patient is suspected of IE or a cardiac abscess. Empiric broad-spectrum antibiotics until further characterization of infective species should be monitored for at least 6 weeks of therapy in this patient population.
  • Supportive treatment includes the following:
    • Fluid and electrolyte balance
    • Nutritional support

Surgical Treatment

  • Surgery consult and the time of surgical intervention is of high importance when approaching a patient with a cardiac abscess.
  • There is increased morbidity and mortality in patients in whom surgery is delayed. Thus early surgery is recommended. Surgery for these patients aims toward the eradication of the infection and correction of hemodynamic abnormalities.
  • However, some patients with periannular extension of infection or myocardial abscess could potentially be treated without surgical intervention. These patients include:
    • Patients with smaller (less than 1 cm) abscesses
    • Patients who do not have complications of heart block, an echocardiographic progression of abscess during antibiotic therapy
    • Patients who do not have valvular dehiscence or insufficiency
  • It is recommended that patients who do not undergo surgery are monitored closely with serial TEE repeated at 2, 4, and 8 weeks after completion of antibiotic therapy.

References

  1. Kim JS, Kang MK, Cho AJ, Seo YB, Kim KI (May 2017). "Complicated infective endocarditis: a case series". J Med Case Rep. 11 (1): 128. doi:10.1186/s13256-017-1274-7. PMC 5423006. PMID 28482860.
  2. Tennant R, H.W. Parks: Myocardial abscesses. Arch Pathol 68,112-6 (1959)
  3. Narula J, B.A. Khaw, W. Dec, I.F. Palacios, J.F. Southern, J.T. Fallon, H.W. Strauss, E. Haber, T. Yasuda: Recognition of acute myocarditis masquerading as acute myocardial infarction. NEJM 328,100-4 (1993)
  4. Oliveira J, Santos M, Arnoni RT, Ramos A, Togna DD, Ghorayeb SK, Kroll R, Souza L (2018). "Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis". Braz J Cardiovasc Surg. 33 (1): 32–39. doi:10.21470/1678-9741-2017-0132. PMC 5873776. PMID 29617499. Vancouver style error: initials (help)
  5. Howitt T: Remarkable case of abscess of the heart. Lancet 1, 684-685 (1846)
  6. Abela GS, B. Majmudar, J.M. Felner: Myocardial abscess unassociated with infective endocarditis. South Med J 74, 432-434 (1981)
  7. Howitt T: Remarkable case of abscess of the heart. Lancet 1, 684-685 (1846)
  8. Abela GS, B. Majmudar, J.M. Felner: Myocardial abscess unassociated with infective endocarditis. South Med J 74, 432-434 (1981)
  9. Saphir O: Myocarditis: A general review, with an analysis of two hundred and forty cases. Arch Pathol 32,1000-1051 (1941)
  10. Flaxman N: Myocardial abscess. JAMA 122, 804-806 (1943)
  11. Sanson J, S. Slodki, J.G. Gruhn: Myocardial abscesses. Am Heart J 66, 301-308 (1963)
  12. Weiss S, R.W. Wilkins: Myocardial abscess with perforation of the heart. Am J Med Sci 194,199-205 (1937)
  13. TEDESCHI CG, STEVENSON TD, LEVENSON HM (December 1950). "Abscess formation in myocardial infarction". N. Engl. J. Med. 243 (26): 1024–7. doi:10.1056/NEJM195012282432602. PMID 14785774.
  14. Bateman AC, M. Richards, A.P. Pallett. Fatal myocarditis associated with a Lancefield Group B Streptococcus. J Infect 36,354-5 (1998)
  15. Von Kurnatowski HA, J.L.Sierra-Callejas, W. Henkel: Foudroyant todlich verlaufende myokarditis durch streptokokken der gruppe B. Dtsch Med Wschr 103,439-41 (1977)
  16. Tedeschi CG, T.D. Stevenson, H.M. Levenson. Abscess formation in myocardial infarction. NEJM 243,1024-7 (1950)
  17. Saphir O: Meningococcus myocarditis. Am J Pathol 12,677-87 (1936)
  18. McCue MJ, E.E. Moore: Myocarditis with microabscess formation caused by Listeria monocytogenes associated with myocardial infarct. Human Pathol 10:469-72 (1979)
  19. Lewis JF: Myocardial infarction during pregnancy: With associated myocardial Bacteroides abscess. South Med J 66,379-1 (1973)
  20. Ramos Tuarez FJ, Law MA. PMID 29083576. Missing or empty |title= (help)
  21. Zeineddin M, Stewart JA (July 1988). "Echocardiographic detection of non-valve-ring myocardial abscess complicating aortic valve endocarditis". Am. J. Med. 85 (1): 97–9. doi:10.1016/0002-9343(88)90510-4. PMID 3389387.
  22. Akins EW, Slone RM, Wiechmann BN, Browning M, Martin TD, Mayfield WR (June 1991). "Perivalvular pseudoaneurysm complicating bacterial endocarditis: MR detection in five cases". AJR Am J Roentgenol. 156 (6): 1155–8. doi:10.2214/ajr.156.6.2028858. PMID 2028858.
  23. Kim HS, Weilbaecher DG, Lie JT, Titus JL (July 1978). "Myocardial abscesses". Am. J. Clin. Pathol. 70 (1): 18–23. doi:10.1093/ajcp/70.1.18. PMID 696668.
  24. Brenes-Salazar JA (2014). "Westermark's and Palla's signs in acute and chronic pulmonary embolism: Still valid in the current computed tomography era". J Emerg Trauma Shock. 7 (1): 57–8. doi:10.4103/0974-2700.125645. PMC 3912657. PMID 24550636.
  25. "CT Angiography of Pulmonary Embolism: Diagnostic Criteria and Causes of Misdiagnosis | RadioGraphics".
  26. Bĕlohlávek J, Dytrych V, Linhart A (2013). "Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism". Exp Clin Cardiol. 18 (2): 129–38. PMC 3718593. PMID 23940438.
  27. "Pulmonary Embolism: Symptoms - National Library of Medicine - PubMed Health".
  28. Ramani GV, Uber PA, Mehra MR (2010). "Chronic heart failure: contemporary diagnosis and management". Mayo Clin. Proc. 85 (2): 180–95. doi:10.4065/mcp.2009.0494. PMC 2813829. PMID 20118395.
  29. Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL (2008). "Symptom distress and quality of life in patients with advanced congestive heart failure". J Pain Symptom Manage. 35 (6): 594–603. doi:10.1016/j.jpainsymman.2007.06.007. PMC 2662445. PMID 18215495.
  30. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009). "Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology". Eur. J. Heart Fail. 11 (2): 130–9. doi:10.1093/eurjhf/hfn013. PMC 2639415. PMID 19168510.
  31. Takasugi JE, Godwin JD (1998). "Radiology of chronic obstructive pulmonary disease". Radiol. Clin. North Am. 36 (1): 29–55. PMID 9465867.
  32. Wedzicha JA, Donaldson GC (2003). "Exacerbations of chronic obstructive pulmonary disease". Respir Care. 48 (12): 1204–13, discussion 1213–5. PMID 14651761.
  33. Nakawah MO, Hawkins C, Barbandi F (2013). "Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome". J Am Board Fam Med. 26 (4): 470–7. doi:10.3122/jabfm.2013.04.120256. PMID 23833163.
  34. Khandaker MH, Espinosa RE, Nishimura RA, Sinak LJ, Hayes SN, Melduni RM, Oh JK (2010). "Pericardial disease: diagnosis and management". Mayo Clin. Proc. 85 (6): 572–93. doi:10.4065/mcp.2010.0046. PMC 2878263. PMID 20511488.
  35. Bogaert J, Francone M (2013). "Pericardial disease: value of CT and MR imaging". Radiology. 267 (2): 340–56. doi:10.1148/radiol.13121059. PMID 23610095.
  36. Gharib AM, Stern EJ (2001). "Radiology of pneumonia". Med. Clin. North Am. 85 (6): 1461–91, x. PMID 11680112.
  37. Schmidt WA (2013). "Imaging in vasculitis". Best Pract Res Clin Rheumatol. 27 (1): 107–18. doi:10.1016/j.berh.2013.01.001. PMID 23507061.
  38. Suresh E (2006). "Diagnostic approach to patients with suspected vasculitis". Postgrad Med J. 82 (970): 483–8. doi:10.1136/pgmj.2005.042648. PMC 2585712. PMID 16891436.
  39. Stein PD, Dalen JE, McIntyre KM, Sasahara AA, Wenger NK, Willis PW (1975). "The electrocardiogram in acute pulmonary embolism". Prog Cardiovasc Dis. 17 (4): 247–57. PMID 123074.
  40. Warnier MJ, Rutten FH, Numans ME, Kors JA, Tan HL, de Boer A, Hoes AW, De Bruin ML (2013). "Electrocardiographic characteristics of patients with chronic obstructive pulmonary disease". COPD. 10 (1): 62–71. doi:10.3109/15412555.2012.727918. PMID 23413894.
  41. Stein PD, Matta F, Ekkah M, Saleh T, Janjua M, Patel YR, Khadra H (2012). "Electrocardiogram in pneumonia". Am. J. Cardiol. 110 (12): 1836–40. doi:10.1016/j.amjcard.2012.08.019. PMID 23000104.
  42. Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, Merken J, Kuznetsova T, Staessen JA, Brunner-La Rocca HP, van Paassen P, Cohen Tervaert JW, Heymans S (2015). "Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis". Int. J. Cardiol. 199: 170–9. doi:10.1016/j.ijcard.2015.06.087. PMID 26209947.
  43. Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Tervaert JW, Heymans S (2010). "Cardiac involvement in Churg-Strauss syndrome". Arthritis Rheum. 62 (2): 627–34. doi:10.1002/art.27263. PMID 20112390.
  44. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH (March 2009). "Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study". Arch. Intern. Med. 169 (5): 463–73. doi:10.1001/archinternmed.2008.603. PMC 3625651. PMID 19273776.
  45. 45.0 45.1 Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y (1992). "Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system". Ann Biol Clin (Paris). 50 (6–7): 393–7. PMID 1492717.


Template:WikiDoc Sources